Dr. Yajnik is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St Blk 4
Gastroenterology Associates
Boston, MA 02114Phone+1 617-724-6005Fax+1 617-726-3080
Education & Training
- Massachusetts General HospitalFellowship, Gastroenterology, 1998 - 2001
- Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1998
- New York University School of MedicineClass of 1996
Certifications & Licensure
- MA State Medical License 1999 - 2018
Clinical Trials
- Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis Start of enrollment: 2012 Feb 01
- Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease Start of enrollment: 2014 Feb 01
- GI Complications in Cancer Immunotherapy Patients Start of enrollment: 2015 Aug 01
Publications & Presentations
PubMed
- Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study.Alexander J Prokopienko, Junyao Wang, Vijay Yajnik, Mike Baratta, Nirav K Desai
Journal of Clinical Pharmacology. 2025-02-01 - 8 citationsENTERPRET: A Randomized Controlled Trial of Vedolizumab Dose Optimization in Patients With Ulcerative Colitis Who Have Early Nonresponse.Vipul Jairath, Andres Yarur, Mark T Osterman, Alexandra James, Diane Balma
Clinical Gastroenterology and Hepatology. 2024-05-01 - 9 citationsGut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis.Pablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, Rafael S Czepielewski, Bram Verstockt
Science Immunology. 2024-04-19
Journal Articles
- Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel DiseasesHamed Khalili, John J Garber, Ramnik J Xavier, Ashwin N Ananthakrishnan, Vijay Yajnik, Journal of Crohn's and Colitis
Press Mentions
- FDA to Review SC Formulation of Vedolizumab for Ulcerative ColitisApril 27th, 2023
- Innovations in Inflammatory Bowel DiseaseFebruary 10th, 2016
- Worcester Doctor’s Medical License SuspendedMay 23rd, 2018
Grant Support
- Identification Of Genes Involved In Cancer ProgressionNational Institute Of Diabetes And Digestive And Kidney Diseases2002–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: